中文版 | English
Title

Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate

Author
Corresponding AuthorLi, Zhi-jie; Jiang, Yong; Wang, Ji-gang
Publication Years
2023-04-01
DOI
Source Title
ISSN
1671-4083
EISSN
1745-7254
Abstract
Liver, as an immune and detoxification organ, represents an important line of defense against bacteria and infection and a vulnerable organ that is easily injured during sepsis. Artesunate (ART) is an anti-malaria agent, that also exhibits broad pharmacological activities including anti-inflammatory, immune-regulation and liver protection. In this study, we investigated the cellular responses in liver to sepsis infection and ART hepatic-protective mechanisms against sepsis. Cecal ligation and puncture (CLP)-induced sepsis model was established in mice. The mice were administered ART (10 mg/kg, i.p.) at 4 h, and sacrificed at 12 h after the surgery. Liver samples were collected for preparing single-cell RNA transcriptome sequencing (scRNA-seq). The scRNA-seq analysis revealed that sepsis-induced a dramatic reduction of hepatic endothelial cells, especially the subtypes characterized with proliferation and differentiation. Macrophages were recruited during sepsis and released inflammatory cytokines (Tnf, Il1b, Il6), chemokines (Ccl6, Cd14), and transcription factor ( Nfkb1), resulting in liver inflammatory responses. Massive apoptosis of lymphocytes and abnormal recruitment of neutrophils caused immune dysfunction. ART treatment significantly improved the survival of CLP mice within 96 h, and partially relieved or reversed the above-mentioned pathological features, mitigating the impact of sepsis on liver injury, inflammation, and dysfunction. This study provides comprehensive fundamental proof for the liver protective efficacy of ART against sepsis infection, which would potentially contribute to its clinical translation for sepsis therapy.
Keywords
URL[Source Record]
Indexed By
Language
English
SUSTech Authorship
Corresponding
Funding Project
Establishment of Sino-Austria "Belt and Road" Joint Laboratory on Traditional Chinese Medicine for Severe Infectious Diseases and Joint Research[2020YFE0205100] ; National Key Research and Development Program of China["2020YFA0908000","2022YFC2303600"] ; Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine[ZYYCXTD-C-202002] ; National Natural Science Foundation of China["82141001","82274182","82074098","82173914"] ; CACMS Innovation Fund["CI2021A05101","CI2021A05104"] ; Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences[CI2021B014] ; Science and Technology Foundation of Shenzhen[JCYJ20210324115800001] ; Fundamental Research Funds for the Central Public Welfare Research Institutes["ZZ14-YQ-050","ZZ14-YQ-051","ZZ14-YQ-052","ZZ14-FL-002","ZZ14-ND-010","ZZ15-ND-10"] ; Shenzhen Governmental Sustainable Development Fund[KCXFZ20201221173612034] ; Shenzhen Key Laboratory of Kidney Diseases[ZDSYS201504301616234] ; Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties[SZGSP001]
WOS Research Area
Chemistry ; Pharmacology & Pharmacy
WOS Subject
Chemistry, Multidisciplinary ; Pharmacology & Pharmacy
WOS Accession No
WOS:000969020000001
Publisher
ESI Research Field
PHARMACOLOGY & TOXICOLOGY
Data Source
Web of Science
Citation statistics
Cited Times [WOS]:1
Document TypeJournal Article
Identifierhttp://kc.sustech.edu.cn/handle/2SGJ60CL/583130
DepartmentShenzhen People's Hospital
Affiliation
1.China Acad Chinese Med Sci, Artemisinin Res Ctr, Beijing 100700, Peoples R China
2.China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China
3.Southern Univ Sci & Technol, Shenzhen Peoples Hosp, Affiliated Hosp 1, Dept Nephrol,Shenzhen Key Lab Kidney Dis, Shenzhen 518020, Peoples R China
4.Southern Univ Sci & Technol, Shenzhen Peoples Hosp, Affiliated Hosp 1, Shenzhen Clin Res Ctr Geriatr, Shenzhen 518020, Peoples R China
5.Jiangxi Univ Chinese Med, Natl Pharmaceut Engn Ctr Solid Preparat Chinese He, Nanchang 330004, Peoples R China
6.China Acad Chinese Med Sci, Beijing 100700, Peoples R China
7.Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore
8.Stanford Univ, Sch Med, Adv Drug Delivery & Regenerat Biomat Lab, Stanford, CA 94304 USA
9.Stanford Univ, Sch Med, Cardiovasc Pharmacol Div Cardiovasc Inst, Stanford, CA 94304 USA
10.Southern Med Univ, Sch Basic Med Sci, Guangdong Prov Key Lab Prote, Guangzhou 510515, Peoples R China
First Author AffilicationShenzhen People's Hospital
Corresponding Author AffilicationShenzhen People's Hospital
First Author's First AffilicationShenzhen People's Hospital
Recommended Citation
GB/T 7714
He, Xue-ling,Chen, Jia-yun,Feng, Yu-lin,et al. Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate[J]. ACTA PHARMACOLOGICA SINICA,2023.
APA
He, Xue-ling.,Chen, Jia-yun.,Feng, Yu-lin.,Song, Ping.,Wong, Yin Kwan.,...&Wang, Ji-gang.(2023).Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate.ACTA PHARMACOLOGICA SINICA.
MLA
He, Xue-ling,et al."Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate".ACTA PHARMACOLOGICA SINICA (2023).
Files in This Item:
There are no files associated with this item.
Related Services
Fulltext link
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Export to Excel
Export to Csv
Altmetrics Score
Google Scholar
Similar articles in Google Scholar
[He, Xue-ling]'s Articles
[Chen, Jia-yun]'s Articles
[Feng, Yu-lin]'s Articles
Baidu Scholar
Similar articles in Baidu Scholar
[He, Xue-ling]'s Articles
[Chen, Jia-yun]'s Articles
[Feng, Yu-lin]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[He, Xue-ling]'s Articles
[Chen, Jia-yun]'s Articles
[Feng, Yu-lin]'s Articles
Terms of Use
No data!
Social Bookmark/Share
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.